Axsome Therapeutics, Inc. · NASDAQ:AXSM
Tabuteau Herriot sold 49,664 Axsome Therapeutics, Inc. shares (Form 4)
Traded Aug 5 to Aug 6, 2026 · Filed Aug 7, 2026
From Aug 5 to Aug 6, 2026, Tabuteau Herriot (Director, Chief Executive Officer, 10% owner) sold 49,664 Axsome Therapeutics, Inc. shares at an average US$212.19 for US$10.5M under a trading plan, leaving 7,229 shares. Filed Aug 7, 2026 (Form 4).
- Sold
- 49,664 shares
- Price
- US$212.19 average (US$212.01 to US$213.95)
- Value
- US$10.5M
- Holding after
- 7,229 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 5, 2026 | Common Stock | Option exercise | 45,004 | US$4.95 | 52,233 | Direct |
| Aug 5, 2026 | Common Stock | Sale | 45,004 | US$212.01 | 7,229 | Direct |
| Aug 6, 2026 | Common Stock | Option exercise | 4,660 | US$4.95 | 11,889 | Direct |
| Aug 6, 2026 | Common Stock | Sale | 4,660 | US$213.95 | 7,229 | Direct |
Source
Related
- Axsome Therapeutics, Inc.
- Tabuteau Herriot
- Axsome Therapeutics, Inc. shareholders
- Form 4 · Tabuteau Herriot · Jul 1, 2026
- Form 4 · Tabuteau Herriot · Jun 9, 2026
- Form 4 · Jacobson Mark L. · Sep 3, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Jeffs Roger · Jun 11, 2026
- Form 4 · Mahony Susan · Jun 10, 2026
- Form 4 · Coleman Mark · Jun 10, 2026